Research & KnowledgeEvent: September 2, 2026
PercuSense started its first-in-human ICU study using lactate, tissue oxygen, glucose, and ketone continuously from one probe.
Published
Signal category
Research & Knowledge
Quote
“We've started our first-in-human ICU study: lactate, tissue oxygen, glucose and ketone, continuously, from one probe.”
— Brian Kannard|PercuSense team
Company
PercuSense
Intelligent biosensors to power the future of healthcare
- Industry
- Medical Device
- Location
- Valencia, US
- Company size
- 13 employees
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.